IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin reduce the need for insulin therapy in type 2 diabetes?
Sitagliptin can reduce the need for insulin in type 2 diabetes by enhancing the body's own insulin production and decreasing blood glucose levels.
Sitagliptin can reduce the need for insulin in type 2 diabetes by enhancing the body’s own insulin production and decreasing blood glucose levels.
See lessHow does Sitagliptin affect hepatic glucose production?
Sitagliptin reduces hepatic glucose production by enhancing the activity of GLP-1, which inhibits glucagon release, thus lowering blood glucose levels and aiding glycemic stability in type 2 diabetes.
Sitagliptin reduces hepatic glucose production by enhancing the activity of GLP-1, which inhibits glucagon release, thus lowering blood glucose levels and aiding glycemic stability in type 2 diabetes.
See lessWhat is the mechanism of action of Sitagliptin as a DPP-4 inhibitor?
Sitagliptin inhibits DPP-4, an enzyme that degrades incretin hormones. By preventing this, it increases incretin levels, enhancing insulin release and lowering glucagon, thus improving blood glucose control.
Sitagliptin inhibits DPP-4, an enzyme that degrades incretin hormones. By preventing this, it increases incretin levels, enhancing insulin release and lowering glucagon, thus improving blood glucose control.
See lessHow does Sitagliptin affect fasting glucose levels compared to postprandial glucose?
Sitagliptin reduces fasting glucose by enhancing insulin secretion and lowering glucagon levels, which stabilizes fasting and postprandial levels, reducing overall glycemic variability.
Sitagliptin reduces fasting glucose by enhancing insulin secretion and lowering glucagon levels, which stabilizes fasting and postprandial levels, reducing overall glycemic variability.
See lessCan Sitagliptin be used in combination with basal insulin?
Yes, Sitagliptin can be used with basal insulin. This combination often leads to improved blood sugar control with a reduced risk of hypoglycemia and weight gain.
Yes, Sitagliptin can be used with basal insulin. This combination often leads to improved blood sugar control with a reduced risk of hypoglycemia and weight gain.
See lessHow does Sitagliptin compare to GLP-1 receptor agonists in managing blood glucose?
Sitagliptin, a DPP-4 inhibitor, increases GLP-1 levels subtly, aiding stable blood glucose control with minimal hypoglycemia risk and weight gain. GLP-1 receptor agonists have stronger effects, reducing glucose, promoting weight loss, but may cause gastrointestinal issues and are injectable.
Sitagliptin, a DPP-4 inhibitor, increases GLP-1 levels subtly, aiding stable blood glucose control with minimal hypoglycemia risk and weight gain. GLP-1 receptor agonists have stronger effects, reducing glucose, promoting weight loss, but may cause gastrointestinal issues and are injectable.
See lessWhat is the recommended dose of Sitagliptin for newly diagnosed patients?
The standard dose of Sitagliptin for type 2 diabetes is 100 mg once daily. Dosing may be adjusted based on kidney function, with reductions to 50 mg or 25 mg daily if necessary.
The standard dose of Sitagliptin for type 2 diabetes is 100 mg once daily. Dosing may be adjusted based on kidney function, with reductions to 50 mg or 25 mg daily if necessary.
See lessHow does Sitagliptin improve glycemic control in patients with insulin resistance?
Sitagliptin enhances insulin secretion and reduces glucagon levels, improving glycemic control but does not directly affect glucose uptake in peripheral tissues.
Sitagliptin enhances insulin secretion and reduces glucagon levels, improving glycemic control but does not directly affect glucose uptake in peripheral tissues.
See lessWhat are the long-term benefits of Sitagliptin in diabetes management?
1. Sitagliptin has proven effective in preserving beta-cell function over time, reducing the progression of diabetes and decreasing the need for insulin therapy. 2. Long-term benefits of Sitagliptin include its ability to moderate blood sugar levels, which helps prevent serious diabetic complicationRead more
1. Sitagliptin has proven effective in preserving beta-cell function over time, reducing the progression of diabetes and decreasing the need for insulin therapy.
2. Long-term benefits of Sitagliptin include its ability to moderate blood sugar levels, which helps prevent serious diabetic complications such as neuropathy and retinopathy.
3. Sitagliptin helps in maintaining glucose levels and has a low risk of hypoglycemia, supporting sustained beta-cell health and function, crucial for long-term diabetes management.
See lessHow does Sitagliptin impact insulin secretion after meals?
Sitagliptin enhances insulin release post-meal by inhibiting DPP-4, which increases incretin levels, reducing postprandial glucose spikes in diabetics.
Sitagliptin enhances insulin release post-meal by inhibiting DPP-4, which increases incretin levels, reducing postprandial glucose spikes in diabetics.
See less